The International Society for Infectious Diseases (ISID), established in 1986, is a nonprofit organization that works to control infectious disease outbreaks and improve the care of patients afflicted with these conditions
The Latest Bing News on:
International Society for Infectious Diseases Research
- International Decade of Sciences for Sustainable Development
The resolution International Decade of Sciences for Sustainable Development 2024-2033 (Sciences Decade) was adopted by the United Nations General Assembly (UNGA) in August 2023. T ...
- International Decade of Sciences for Sustainable Development Forum opens in Beijing
BEIJING, April 28, 2024 /PRNewswire/ -- A news report from CRI Online: ...
- Enhancing Health Communication for Epidemic Prevention
Effective public health communication is essential for Africa, confronted with numerous infectious disease epidemics and public health crises.
- Europe Strengthens Future Disease Defense
A network of countries and health agencies will coordinate a strategy to identify and mitigate future disease threats.
- The WHO updates its terminology for pathogens that transmit through the air
The World Health Organization published a consensus statement on airborne pathogens, finally aligning the WHO with scientists who presented evidence of this early in the course of the COVID-19 ...
The Latest Bing News on:
International Society for Infectious Diseases Discovery
- International Decade of Sciences for Sustainable Development Forum opens in Beijing
UNESCO, in collaboration with the Ministry of Science and Technology of the People's Republic of China and the People's Government of Beijing Municipality, co-organized the "International Decade of ...
- Why Latin America needs a regional Centre for Disease Control and Prevention
Home to about 8·2% of the global population, Latin America experienced a disproportionate burden of COVID-19. The region reported 80 million COVID-19 cases and 1·7 million deaths, representing 10% and ...
- 2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for ...
- Federal bill would track deadly virus sales, try to prevent repeat of illegal Reedley lab
More than a year after the city of Reedley first encountered state and federal roadblocks in dealing with an illegal biological laboratory, new federal legislation is aimed at better tracking who are ...
- Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
So far, toripalimab has been approved for marketing in the Chinese mainland and the US. Several NDAs are currently under regulatory review in the European Union, UK, Australia, Singapore, Malaysia and ...
